New Hampshire Trust’s DexCom DXCM Stock Holding History

New Hampshire Trust’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-881	Closed	-$102K	–	212
2023 Q1	$102K	Hold	881	–	–	0.03%	213
2022 Q4	$99.8K	Buy	+881	New	+$96.7K	0.03%	212

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

New Hampshire Trust's DXCM Position: Q2 2023 in Review

New Hampshire Trust sold out of DexCom (DXCM) in Q2 2023, closing a stake of 881 shares — an estimated $102K sold.

New Hampshire Trust first reported a position in DXCM in Q4 2022 and held it in 2 quarters. The position peaked at $102K in Q1 2023. 954 funds tracked by Wall St. Rank hold DXCM as of Q2 2023.

New Hampshire Trust reported no remaining DexCom position as of Q2 2023 after selling out during the quarter.
New Hampshire Trust sold 881 DexCom shares in Q2 2023, an estimated $102K.
New Hampshire Trust first reported a position in DexCom in Q4 2022 and held it in 2 quarters.
New Hampshire Trust's DexCom position peaked at $102K in Q1 2023.
954 funds tracked by Wall St. Rank held DexCom as of Q2 2023.

Based on New Hampshire Trust's 13F filing for Q2 2023, filed 11 Jul 2023.